These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 29844251)

  • 1. Human Fibrinogen: Molecular and Genetic Aspects of Congenital Disorders.
    Tiscia GL; Margaglione M
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29844251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory and Genetic Investigation of Mutations Accounting for Congenital Fibrinogen Disorders.
    Neerman-Arbez M; de Moerloose P; Casini A
    Semin Thromb Hemost; 2016 Jun; 42(4):356-65. PubMed ID: 27019463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital fibrinogen disorders: an update.
    de Moerloose P; Casini A; Neerman-Arbez M
    Semin Thromb Hemost; 2013 Sep; 39(6):585-95. PubMed ID: 23852822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of congenital fibrinogen disorders.
    Lebreton A; Casini A
    Ann Biol Clin (Paris); 2016 Aug; 74(4):405-12. PubMed ID: 27492693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of fibrinogen deficiency.
    Neerman-Arbez M
    Pathophysiol Haemost Thromb; 2006; 35(1-2):187-98. PubMed ID: 16855369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Two Novel Fibrinogen Bβ Chain Mutations in Two Slovak Families with Quantitative Fibrinogen Disorders.
    Simurda T; Zolkova J; Snahnicanova Z; Loderer D; Skornova I; Sokol J; Hudecek J; Stasko J; Lasabova Z; Kubisz P
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations Accounting for Congenital Fibrinogen Disorders: An Update.
    Richard M; Celeny D; Neerman-Arbez M
    Semin Thromb Hemost; 2022 Nov; 48(8):889-903. PubMed ID: 35073585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital fibrinogen disorders.
    de Moerloose P; Neerman-Arbez M
    Semin Thromb Hemost; 2009 Jun; 35(4):356-66. PubMed ID: 19598064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital Afibrinogenemia and Hypofibrinogenemia: Laboratory and Genetic Testing in Rare Bleeding Disorders with Life-Threatening Clinical Manifestations and Challenging Management.
    Simurda T; Asselta R; Zolkova J; Brunclikova M; Dobrotova M; Kolkova Z; Loderer D; Skornova I; Hudecek J; Lasabova Z; Stasko J; Kubisz P
    Diagnostics (Basel); 2021 Nov; 11(11):. PubMed ID: 34829490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two novel mutations in the fibrinogen γ nodule.
    Kotlín R; Pastva O; Stikarová J; Hlaváčková A; Suttnar J; Chrastinová L; Riedel T; Salaj P; Dyr JE
    Thromb Res; 2014 Oct; 134(4):901-8. PubMed ID: 25074738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital afibrinogenemia: Identification and characterization of two novel homozygous fibrinogen Aα and Bβ chain mutations in two Tunisian families.
    Amri Y; Toumi Nel H; Hadj Fredj S; de Moerloose P
    Thromb Res; 2016 Jul; 143():11-6. PubMed ID: 27164460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary Hypofibrinogenemia with Hepatic Storage.
    Asselta R; Paraboschi EM; Duga S
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Women With Congenital Hypofibrinogenemia/Afibrinogenemia: From Birth to Death.
    Zhang Y; Zuo X; Teng Y
    Clin Appl Thromb Hemost; 2020; 26():1076029620912819. PubMed ID: 32233805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Consequences and Molecular Bases of Low Fibrinogen Levels.
    Neerman-Arbez M; Casini A
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29316703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital structural and functional fibrinogen disorders: a primer for internists.
    Undas A; Casini A
    Pol Arch Intern Med; 2019 Dec; 129(12):913-920. PubMed ID: 31797863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Features and Management of Congenital Fibrinogen Deficiencies.
    Casini A; de Moerloose P; Neerman-Arbez M
    Semin Thromb Hemost; 2016 Jun; 42(4):366-74. PubMed ID: 27019462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetics of quantitative fibrinogen disorders.
    Asselta R; Spena S; Duga S; Tenchini ML
    Cardiovasc Hematol Agents Med Chem; 2007 Apr; 5(2):163-73. PubMed ID: 17430139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of congenital fibrinogen disorders.
    de Moerloose P; Neerman-Arbez M
    Expert Opin Biol Ther; 2008 Jul; 8(7):979-92. PubMed ID: 18549327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of pregnancy and delivery in congenital fibrinogen disorders: communication from the ISTH SSC Subcommittee on Factor XIII and Fibrinogen.
    Casini A; Abdul Kadir R; Abdelwahab M; Manco-Johnson MJ; Raut S; Ross C; de Moerloose P; Santoro C; Acharya S
    J Thromb Haemost; 2024 May; 22(5):1516-1521. PubMed ID: 38266678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One Hundred Years of Congenital Fibrinogen Disorders.
    Casini A; Moerloose P; Neerman-Arbez M
    Semin Thromb Hemost; 2022 Nov; 48(8):880-888. PubMed ID: 36055263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.